From another perspective, CD8+ T cells with higher levels of lipids in tumor patients up-regulated the expression of programmed death-1 (PD-1) receptor, which should generally show inhibitory effects; however, the combination of PD-1 inhibitors showed efficient antigen recognition and better antitumor results. Here, CD8A is linked to neoplasm.